نتائج البحث - Praveen Ramakrishnan Geethakumari

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma

    Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma حسب Kandice A. Kapinos, Ellen Hu, Jigar Trivedi, Praveen Ramakrishnan Geethakumari, Ankit Kansagra

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments

    Balancing Quality, Cost, and Access During Delivery of Newer Cellular and Immunotherapy Treatments حسب Praveen Ramakrishnan Geethakumari, Dheepthi P. Ramasamy, Bhagirathbhai Dholaria, Jesús G. Berdeja, Ankit Kansagra

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Increasing Colon Cancer Screening in Primary Care Among African Americans

    Increasing Colon Cancer Screening in Primary Care Among African Americans حسب Ronald E. Myers, Randa Sifri, Constantine Daskalakis, Melissa DiCarlo, Praveen Ramakrishnan Geethakumari, J Cocroft, Christen Minnick, Nancy Brisbon, Sally W. Vernon

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

    A phase 2, multicentre, open‐label trial (<scp>ACE‐LY</scp>‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma حسب Paolo Strati, Morton Coleman, Rebecca Champion, Shuo Ma, Caterina Patti, Moshe Levy, Izidore S. Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, Lihua E. Budde

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer

    The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer حسب Young Kwang Chae, Débora De Melo Gagliato, Sachin Gopalkrishna Pai, Benedito A. Carneiro, Nisha Mohindra, Francis J. Giles, Praveen Ramakrishnan-Geethakumari, Joohyuk Sohn, Shuying Liu, Huiqin Chen, Naoto T. Ueno, Gabriel N. Hortobágyi, Ana M. González-Angulo

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study

    Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study حسب Pallawi Torka, Natalie S. Grover, Timothy Voorhees, Reem Karmali, Kaitlin Annunzio, Marcus P. Watkins, Andrea Anampa‐Guzmán, Heather Reves, Montreh Tavakkoli, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study

    CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carb... حسب Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph E. Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul Shaughnessy, Armin Ghobadi, Michael Bishop, Ana Alfonso Piérola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William B. Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant-Cohen, Richard T. Maziarz, Carlos Bachier

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers

    Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers حسب Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A. Florindez, Na Hyun Kim, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish Ayyappan, Lauren Shea, Miriam M. Cortese‐Krott, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Mehdi Hamadani, Natalie S. Grover, Narendranath Epperla

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant

    Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant حسب Michael Scordo, Trent Wang, Kwang Woo Ahn, Yue Chen, Sairah Ahmed, Farrukh T. Awan, Amer Beitinjaneh, Andy Chen, Victor A. Chow, Bhagirathbhai Dholaria, Narendranath Epperla, Umar Farooq, Nilanjan Ghosh, Natalie S. Grover, Nada Hamad, Gerhard Hildebrandt, Leona Holmberg, Sanghee Hong, David J. Inwards, Antonio Martin Jimenez-Jimenez, Reem Karmali, Vaishalee P. Kenkre, Farhad Khimani, Evgeny Klyuchnikov, Maxwell M. Krem, Pashna N. Munshi, Yago Nieto, Tim Prestidge, Praveen Ramakrishnan Geethakumari, Andrew R. Rezvani, Peter A. Riedell, Sachiko Seo, Nirav N. Shah, Melhem Solh, Jean A. Yared, Mohamed A. Kharfan‐Dabaja, Alex F. Herrera, Mehdi Hamadani, Craig S. Sauter

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

    Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure حسب Sonali M. Smith, James Godfrey, Kwang Woo Ahn, Alyssa DiGilio, Sairah Ahmed, Vaibhav Agrawal, Veronika Bachanová, Ulrike Bacher, Asad Bashey, Javier Bolaños‐Meade, Mitchell S. Cairo, Andy Chen, Saurabh Chhabra, Edward A. Copelan, Parastoo B. Dahi, Mahmoud Aljurf, Umar Farooq, Siddhartha Ganguly, Mark Hertzberg, Leona Holmberg, David J. Inwards, Abraham S. Kanate, Reem Karmali, Vaishalee P. Kenkre, Mohamed A. Kharfan‐Dabaja, Andreas K. Klein, Hillard M. Lazarus, Matthew Mei, Alberto Mussetti, Taiga Nishihori, Praveen Ramakrishnan Geethakumari, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Nirav N. Shah, Álvaro Urbano-Ispízua, Ravi Vij, Julie M. Vose, Anna Sureda, Mehdi Hamadani

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: